Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection
<i>Mycobacterium tuberculosis</i>, the causative agent of tuberculosis (TB), remains a global health burden. While <i>M. tuberculosis</i> is primarily a respiratory pathogen, it can spread to other organs, including the brain and meninges, causing TB meningitis (TBM). However...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2024
|
| _version_ | 1824459010531655680 |
|---|---|
| author | Spatola, M Nziza, N Irvine, EB Cizmeci, D Jung, W Van, LH Nhat, LTH Ha, VTN Phu, NH Nghia, HDT Thwaites, GE Lauffenburger, DA Fortune, S Thuong, NTT Alter, G |
| author_facet | Spatola, M Nziza, N Irvine, EB Cizmeci, D Jung, W Van, LH Nhat, LTH Ha, VTN Phu, NH Nghia, HDT Thwaites, GE Lauffenburger, DA Fortune, S Thuong, NTT Alter, G |
| author_sort | Spatola, M |
| collection | OXFORD |
| description | <i>Mycobacterium tuberculosis</i>, the causative agent of tuberculosis (TB), remains a global health burden. While <i>M. tuberculosis</i> is primarily a respiratory pathogen, it can spread to other organs, including the brain and meninges, causing TB meningitis (TBM). However, little is known about the immunological mechanisms that lead to differential disease across organs. Attention has focused on differences in T cell responses in the control of <i>M. tuberculosis</i> in the lungs, but emerging data point to a role for antibodies, as both biomarkers of disease control and as antimicrobial molecules. Given an increasing appreciation for compartmentalized antibody responses across the blood–brain barrier, here we characterized the antibody profiles across the blood and brain compartments in TBM and determined whether <i>M. tuberculosis</i>-specific humoral immune responses differed between <i>M. tuberculosis</i> infection of the lung (pulmonary TB) and TBM.
<br>
Using a high throughput systems serology approach, we deeply profiled the antibody responses against 10 different <i>M. tuberculosis</i> antigens, including lipoarabinomannan (LAM) and purified protein derivative (PPD), in HIV-negative adults with pulmonary TB (n = 10) versus TBM (n = 60). Antibody studies included analysis of immunoglobulin isotypes (IgG, IgM, IgA) and subclass levels (IgG1–4) and the capacity of <i>M. tuberculosis</i>-specific antibodies to bind to Fc receptors or C1q and to activate innate immune effector functions (complement and natural killer cell activation; monocyte or neutrophil phagocytosis). Machine learning methods were applied to characterize serum and CSF responses in TBM, identify prognostic factors associated with disease severity, and define the key antibody features that distinguish TBM from pulmonary TB.
<br>
In individuals with TBM, we identified CSF-specific antibody profiles that marked a unique and compartmentalized humoral response against <i>M. tuberculosis</i>, characterized by an enrichment of <i>M. tuberculosis</i>-specific antibodies able to robustly activate complement and drive phagocytosis by monocytes and neutrophils, all of which were associated with milder TBM severity at presentation. Moreover, individuals with TBM exhibited <i>M. tuberculosis</i>-specific antibodies in the serum with an increased capacity to activate phagocytosis by monocytes, compared with individuals with pulmonary TB, despite having lower IgG titres and Fcγ receptor-binding capacity.
<br>
Collectively, these data point to functionally divergent humoral responses depending on the site of infection (i.e. lungs versus brain) and demonstrate a highly compartmentalized <i>M. tuberculosis</i>-specific antibody response within the CSF in TBM. Moreover, our results suggest that phagocytosis- and complement-mediating antibodies may promote attenuated neuropathology and milder TBM disease. |
| first_indexed | 2025-02-19T04:34:59Z |
| format | Journal article |
| id | oxford-uuid:91cc1ac4-401b-48e6-b2e2-1c1373f9841f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2025-02-19T04:34:59Z |
| publishDate | 2024 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:91cc1ac4-401b-48e6-b2e2-1c1373f9841f2025-01-24T12:08:18ZDistinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:91cc1ac4-401b-48e6-b2e2-1c1373f9841fEnglishSymplectic ElementsOxford University Press2024Spatola, MNziza, NIrvine, EBCizmeci, DJung, WVan, LHNhat, LTHHa, VTNPhu, NHNghia, HDTThwaites, GELauffenburger, DAFortune, SThuong, NTTAlter, G<i>Mycobacterium tuberculosis</i>, the causative agent of tuberculosis (TB), remains a global health burden. While <i>M. tuberculosis</i> is primarily a respiratory pathogen, it can spread to other organs, including the brain and meninges, causing TB meningitis (TBM). However, little is known about the immunological mechanisms that lead to differential disease across organs. Attention has focused on differences in T cell responses in the control of <i>M. tuberculosis</i> in the lungs, but emerging data point to a role for antibodies, as both biomarkers of disease control and as antimicrobial molecules. Given an increasing appreciation for compartmentalized antibody responses across the blood–brain barrier, here we characterized the antibody profiles across the blood and brain compartments in TBM and determined whether <i>M. tuberculosis</i>-specific humoral immune responses differed between <i>M. tuberculosis</i> infection of the lung (pulmonary TB) and TBM. <br> Using a high throughput systems serology approach, we deeply profiled the antibody responses against 10 different <i>M. tuberculosis</i> antigens, including lipoarabinomannan (LAM) and purified protein derivative (PPD), in HIV-negative adults with pulmonary TB (n = 10) versus TBM (n = 60). Antibody studies included analysis of immunoglobulin isotypes (IgG, IgM, IgA) and subclass levels (IgG1–4) and the capacity of <i>M. tuberculosis</i>-specific antibodies to bind to Fc receptors or C1q and to activate innate immune effector functions (complement and natural killer cell activation; monocyte or neutrophil phagocytosis). Machine learning methods were applied to characterize serum and CSF responses in TBM, identify prognostic factors associated with disease severity, and define the key antibody features that distinguish TBM from pulmonary TB. <br> In individuals with TBM, we identified CSF-specific antibody profiles that marked a unique and compartmentalized humoral response against <i>M. tuberculosis</i>, characterized by an enrichment of <i>M. tuberculosis</i>-specific antibodies able to robustly activate complement and drive phagocytosis by monocytes and neutrophils, all of which were associated with milder TBM severity at presentation. Moreover, individuals with TBM exhibited <i>M. tuberculosis</i>-specific antibodies in the serum with an increased capacity to activate phagocytosis by monocytes, compared with individuals with pulmonary TB, despite having lower IgG titres and Fcγ receptor-binding capacity. <br> Collectively, these data point to functionally divergent humoral responses depending on the site of infection (i.e. lungs versus brain) and demonstrate a highly compartmentalized <i>M. tuberculosis</i>-specific antibody response within the CSF in TBM. Moreover, our results suggest that phagocytosis- and complement-mediating antibodies may promote attenuated neuropathology and milder TBM disease. |
| spellingShingle | Spatola, M Nziza, N Irvine, EB Cizmeci, D Jung, W Van, LH Nhat, LTH Ha, VTN Phu, NH Nghia, HDT Thwaites, GE Lauffenburger, DA Fortune, S Thuong, NTT Alter, G Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title | Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title_full | Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title_fullStr | Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title_full_unstemmed | Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title_short | Distinctive antibody responses to Mycobacterium tuberculosis in pulmonary and brain infection |
| title_sort | distinctive antibody responses to mycobacterium tuberculosis in pulmonary and brain infection |
| work_keys_str_mv | AT spatolam distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT nzizan distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT irvineeb distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT cizmecid distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT jungw distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT vanlh distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT nhatlth distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT havtn distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT phunh distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT nghiahdt distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT thwaitesge distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT lauffenburgerda distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT fortunes distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT thuongntt distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection AT alterg distinctiveantibodyresponsestomycobacteriumtuberculosisinpulmonaryandbraininfection |